also using tdm1 in a phase 1 trial with pertuzumab...
now 5 trials will be enrolling shortly using tdm1.
they also expect to file for an accelerated approval based on positive data from the newly announced phase 3 trial, and the phase 2 trial for patients who have failed tykerb.
Threaded Mode